Compounds > moricizine
Page last updated: 2024-08-23

moricizine and Anomalous Ventricular Excitation Syndrome

moricizine has been researched along with Anomalous Ventricular Excitation Syndrome in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chazov, EI; Rosenshtraukh, LV; Shugushev, KK1
Rozenshtraukh, LV; Shugushev, KhKh; Smetnev, AS1
Chen, X; Pu, JL; Sun, RL1
Kenda, MF; Rakovec, P1

Other Studies

4 other study(ies) available for moricizine and Anomalous Ventricular Excitation Syndrome

ArticleYear
Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
    American heart journal, 1984, Volume: 108, Issue:3 Pt 1

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrioventricular Node; Bundle of His; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Conduction System; Humans; Infusions, Parenteral; Male; Middle Aged; Moricizine; Phenothiazines; Purkinje Fibers; Tachycardia, Paroxysmal; Wolff-Parkinson-White Syndrome

1984
[Electrophysiological evaluation of the anti-arrhythmia activity of ethmozin and its diethylamine analog in patients with Wolff-Parkinson-White syndrome].
    Terapevticheskii arkhiv, 1982, Volume: 54, Issue:5

    Topics: Adolescent; Adult; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Wolff-Parkinson-White Syndrome

1982
[Acute electrophysiologic effects of intravenous ethmozin in patients with paroxysmal supraventricular tachycardia due to WPW syndrome].
    Zhonghua xin xue guan bing za zhi, 1988, Volume: 16, Issue:6

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Child; Electrocardiography; Female; Humans; Male; Middle Aged; Moricizine; Phenothiazines; Tachycardia, Supraventricular; Wolff-Parkinson-White Syndrome

1988
[Effect of the anti-arrhythmia agent ethmozin on the refractory period of the accessory pathway in Wolff-Parkinson-White syndrome].
    Wiener medizinische Wochenschrift (1946), 1986, Feb-15, Volume: 136, Issue:3

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Heart Conduction System; Humans; Moricizine; Phenothiazines; Wolff-Parkinson-White Syndrome

1986